📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-12 16:51
138 analysed today
FollowTelegram
138
Today
150,089
All-time analysed
43,015
Positive
6,671
Negative
91,681
Neutral
8,654
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Crestchem Ltd Approves Q1 FY27 Financial Results in 15-Minute Board Meeting
Crestchem Ltd held a board meeting on August 12, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The meeting was notably brief, concluding in just 15 minutes. While the specific P&L figures were not detailed in the cover letter, the company enters this period with a TTM revenue of Rs 30 Cr and a high ROCE of 43.4%. Investors should monitor the full results for growth relative to the March 2026 quarter's revenue of Rs 10.23 Cr.
Confidence: HIGH
What changedThe company has formally approved and taken on record its financial performance for the first quarter of the 2026-27 fiscal year.
Why it mattersFor a micro-cap company with a market capitalization of only Rs 37 Cr, quarterly earnings are the primary driver of stock liquidity and valuation, especially given its high capital efficiency (ROCE 43.4%).
Meeting Duration: 15 minutesTTM Revenue: Rs 30 CrMarket Cap: Rs 37 CrROCE: 43.4%Debt to Equity: 0.00
📅 Short termStock price movement will depend on the specific revenue and margin growth figures disclosed in the full financial statements relative to the previous quarter's Rs 1.1 Cr profit.
📈 Long termLimited; this is a routine quarterly regulatory requirement, though consistent performance is needed to justify the current P/B of 3.8.
⚠ Risk flags
- Low promoter holding (29.76%)
- Micro-cap liquidity risk
- Client concentration typical of specialty chemicals
Key Highlights
Board meeting conducted and concluded within 15 minutes (4:30 PM to 4:45 PM) on August 12, 2026.
Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Company maintains a debt-free balance sheet (D/E of 0.00) as per latest financial context.
TTM PAT stands at Rs 3 Cr with an operating profit margin of 10.7% leading into this result.
Promoter holding remains relatively low at 29.76% as of June 2026.
👀 What to Watch
Investors should examine the detailed financial tables to verify if the company sustained the sequential revenue growth seen in Mar 2026 (Rs 10.23 Cr vs Rs 7.16 Cr in Dec 2025).
Rs 1.50 Dividend: Crestchem Sets July 30, 2026, as Record Date
Crestchem Ltd has finalized July 30, 2026, as the record date for its FY 2025-26 dividend payment. The dividend is declared at 15%, which translates to Rs 1.50 per equity share. Based on the current market price of Rs 135.5, this represents a dividend yield of approximately 1.1%. The decision follows a board meeting held on July 4, 2026.
Confidence: HIGH
What changedThe company has officially scheduled the record date for its previously decided FY 2025-26 dividend.
Why it mattersThis represents a direct cash return to shareholders, although the yield of ~1.1% is relatively modest compared to the stock's recent 40% price appreciation over 6 months.
Dividend per share: Rs 1.50Dividend percentage: 15%Record Date: July 30, 2026Approximate Dividend Yield: 1.1%
📅 Short termThe stock may experience minor price adjustments around the ex-dividend date as the payout is priced in.
📈 Long termLimited; this is a routine corporate action and does not signify a structural change in business operations.
Key Highlights
Dividend amount fixed at Rs 1.50 per equity share
Record date for eligibility set for July 30, 2026
Dividend payout rate established at 15% of face value
Board approval for the record date was finalized on July 4, 2026
👀 What to Watch
Investors seeking the dividend must ensure they hold the shares before the ex-dividend date (typically one business day prior to the July 30 record date).
Rs 1.50 Dividend: Crestchem Ltd Sets Record Date and 34th AGM Schedule
Crestchem Ltd has announced a dividend of Rs 1.50 per equity share for the financial year, applicable to 30,00,000 equity shares. The record date to determine shareholder eligibility for this dividend and for e-voting at the 34th Annual General Meeting (AGM) is July 30, 2026. The AGM is scheduled for August 06, 2026, with the book closure period running from July 31 to August 06, 2026. At the current share price of Rs 135.5, the dividend yield is approximately 1.11%.
Confidence: HIGH
What changedThe company has finalized the dividend amount and the specific timeline for its annual shareholder meeting and payout eligibility.
Why it mattersThis is a routine but important corporate action providing a cash return to shareholders and setting the stage for annual governance voting.
Dividend per share: Rs 1.50Record Date: July 30, 2026Total Equity Shares: 30,00,000Dividend Yield: ~1.11%AGM Date: August 06, 2026
📅 Short termThe stock may experience minor price adjustments around the ex-dividend date as the market factors in the Rs 1.50 payout.
📈 Long termLimited; this is a routine annual administrative and dividend event with no structural change to business operations.
Key Highlights
Dividend declared at Rs 1.50 per equity share for 30,00,000 shares.
Record date for dividend eligibility and e-voting is July 30, 2026.
34th Annual General Meeting (AGM) scheduled for August 06, 2026.
Book closure period set from July 31, 2026, to August 06, 2026.
Cut-off date for release of AGM Notice and Annual Report was July 10, 2026.
👀 What to Watch
Investors seeking the dividend must ensure they hold the shares before the record date of July 30, 2026. Monitor the AGM on August 06 for management updates on business strategy.
Crestchem FY26: Income Rises 18.6% to ₹25.52 Cr; ₹1.50 Dividend & New Subsidiary Investment
Crestchem Limited reported a total income of ₹25.52 Cr for FY25-26, marking an 18.6% increase from the previous year. Despite the revenue growth, net profit remained nearly flat at ₹2.71 Cr compared to ₹2.73 Cr in FY24-25. The company has proposed a final dividend of ₹1.50 per share (15%) and is seeking approval for a ₹2.75 Cr investment in its newly formed subsidiary, Oleo Biosciences Private Limited. Additionally, the company is renewing five-year management contracts for the Managing Director and Executive Director with revised remuneration.
Confidence: HIGH
What changedThe company has transitioned from a standalone entity to a group structure with the incorporation of Oleo Biosciences and has formalized its FY26 financial performance and dividend payout.
Why it mattersThe flat profit despite higher revenue suggests margin pressure; however, the investment in a new subsidiary (representing ~10.8% of annual revenue) indicates an expansion phase.
Total Income (FY26): ₹25.52 CrNet Profit (FY26): ₹2.71 CrProposed Dividend: ₹1.50 per shareSubsidiary Investment: ₹2.75 CrInvestment vs FY26 Revenue: 10.77%
📅 Short termThe stock may see positive sentiment due to the dividend declaration and the announcement of expansion into a new subsidiary.
📈 Long termLong-term value depends on the successful scaling of Oleo Biosciences and the company's ability to translate revenue growth into higher bottom-line margins.
⚠ Risk flags
- Stagnant net profit despite 18% revenue growth
- Related-party remuneration for non-KMP family members
- Execution risk in the new subsidiary
Key Highlights
Total Income increased to ₹25.52 Cr in FY26 from ₹21.52 Cr in FY25.
Proposed final dividend of ₹1.50 per equity share of ₹10 face value.
Planned investment of ₹2.75 Cr in the new subsidiary Oleo Biosciences Private Limited (incorporated March 2026).
Managing Director's proposed monthly salary set at ₹5,00,000 effective July 2026.
Net Profit for the year stood at ₹2.71 Cr with an EPS of ₹9.04.
👀 What to Watch
Investors should monitor the AGM on August 06, 2026, for the approval of the ₹2.75 Cr subsidiary investment and track the operational progress of Oleo Biosciences as a new growth lever.
